ATE102199T1 - 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen. - Google Patents

4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.

Info

Publication number
ATE102199T1
ATE102199T1 AT89401547T AT89401547T ATE102199T1 AT E102199 T1 ATE102199 T1 AT E102199T1 AT 89401547 T AT89401547 T AT 89401547T AT 89401547 T AT89401547 T AT 89401547T AT E102199 T1 ATE102199 T1 AT E102199T1
Authority
AT
Austria
Prior art keywords
denote
carboxynaphthyridine
derivatives
amino
preparation
Prior art date
Application number
AT89401547T
Other languages
English (en)
Inventor
Etienne Mendes
Jean-Claude Vernieres
Jacques Edouard Simiand
Peter Eugene Keane
Original Assignee
Sanofi Elf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Elf filed Critical Sanofi Elf
Application granted granted Critical
Publication of ATE102199T1 publication Critical patent/ATE102199T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
AT89401547T 1988-06-09 1989-06-05 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen. ATE102199T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8807723A FR2632639B1 (fr) 1988-06-09 1988-06-09 Derives d'amino-4 carboxy-3 naphtyridines, leur preparation et compositions pharmaceutiques qui les contiennent
EP89401547A EP0346207B1 (de) 1988-06-09 1989-06-05 4-Amino-3-carboxynaphthyridin-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE102199T1 true ATE102199T1 (de) 1994-03-15

Family

ID=9367129

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401547T ATE102199T1 (de) 1988-06-09 1989-06-05 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.

Country Status (6)

Country Link
US (1) US4996213A (de)
EP (1) EP0346207B1 (de)
JP (1) JP2815614B2 (de)
AT (1) ATE102199T1 (de)
DE (1) DE68913365T2 (de)
FR (1) FR2632639B1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0169813B1 (ko) * 1995-07-12 1999-01-15 김종인 4-아미노-3-아실나프티리딘 유도체
JPH10242848A (ja) * 1997-02-27 1998-09-11 Nec Corp 半導体集積回路
ZA9810490B (en) 1997-12-03 1999-05-20 Dainippon Pharmaceutical Co 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
DE60128936T2 (de) * 2000-10-12 2008-04-10 Merck & Co, Inc. Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
CA2425625A1 (en) * 2000-10-12 2002-07-18 Merck & Co., Inc. Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
WO2002030931A2 (en) 2000-10-12 2002-04-18 Merck & Co., Inc. Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
AR036256A1 (es) * 2001-08-17 2004-08-25 Merck & Co Inc Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento
CA2472372C (en) * 2002-01-17 2010-08-17 Melissa Egbertson Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
JP4567974B2 (ja) 2002-01-18 2010-10-27 株式会社アドバンテスト 試験装置
WO2003077857A2 (en) * 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
US8575203B2 (en) 2010-04-21 2013-11-05 Boehringer Ingelheim International Gmbh Chemical compounds
DK2753329T3 (en) 2012-01-19 2017-10-23 Onco Therapy Science Inc 1,5-NAPHTHYRIDINE INGREDIENTS AS MILK INHIBITORS
CN117430602A (zh) * 2023-09-26 2024-01-23 爱斯特(成都)生物制药股份有限公司 一种制备6-卤代-4-羟基[1,5]萘啶-3-甲酸酯及其衍生物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4324893A (en) * 1979-04-18 1982-04-13 American Home Products Corporation 4-Amino-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
FR2581382B1 (fr) * 1985-05-06 1987-06-26 Sanofi Sa Derives n-(quinolyl) glycinamides, leur procede de preparation et leur application therapeutique en tant que psychotropes

Also Published As

Publication number Publication date
DE68913365D1 (de) 1994-04-07
US4996213A (en) 1991-02-26
JP2815614B2 (ja) 1998-10-27
JPH0232078A (ja) 1990-02-01
DE68913365T2 (de) 1994-08-11
EP0346207A1 (de) 1989-12-13
FR2632639B1 (fr) 1990-10-05
FR2632639A1 (fr) 1989-12-15
EP0346207B1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
HUP9700777A2 (hu) Ösztrogén hatású 2-fenil-1[4-(2-amino-etoxi)-benzil]-indol-származékok, előállításuk és alkalmazásuk, valamint ezeket a vegyületeket tartalmazó gyógyszerkészítmények
DE68913365D1 (de) 4-Amino-3-carboxynaphthyridin-Derivate, ihre Herstellung und pharmazeutische Zusammensetzungen.
ATE10804T1 (de) Ein diphenylhydantoin-derivat enthaltende pharmazeutische zusammensetzung, verwendete derivate und ihre herstellung.
NO872821D0 (no) Benzhydroloxyethylpiperazinderivater, fremgangsmaater for deres fremstilling og farmasoeytiske blandinger som inneholder dem.
DE69220133D1 (de) N-Cyclohexyl Benzamide Derivate, ihre Herstellungen und therapeutischen Anwendungen
ES2063471T3 (es) Nuevos derivados de guanidina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ES2012648A6 (es) Procedimiento para la preparacion de nuevos derivados de 1,4-benzoxazina y 1,4-benzotiazina.
DE69103968D1 (de) 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik.
SE8802412D0 (sv) Thiourea derivatives
FR2449677B1 (fr) Nouveaux derives de benzoyl-2 glycylanilides substitues, leur preparation et leur application en tant que medicaments anxiolytiques
ES2118343T3 (es) Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
HUP9901137A2 (hu) N-szulfonil- és N-szulfinil-aminosav-származékok, előállításuk, a vegyületeket hatóanyagként tartalmazó mikrobicid készítmények és alkalmazásuk
ATE62687T1 (de) Acylaminomethylimidazo(1,2-a>pyrimidinderivate, ihre herstellung und therapeutische verwendung.
FI902775A0 (fi) Aryloxi-, aryltio-, heteroaryloxi-, heteroaryltio-alkylenderivat av aminer.
DE3783821D1 (de) Tetracyclische indolderivate.
ATE56442T1 (de) 2,6-piperazin-dion-derivate, ihre verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE134607T1 (de) Tetrahydronaphtalenderivate, ihre herstellung und ihre therapeutische verwendung
DK599486A (da) 1,4-dihydropyridiner, deres fremstilling af anvendelse som laegemidler
IL76936A0 (en) 3-amino-2,3-dihydro-1-benzoxepine compounds,their preparation and pharmaceutical compositions containing them
DE69112095D1 (de) 1-Phenoxycarbonyl-2-Pyrrolidon-Derivate und nootrope Wirkstoffe.